News from the healthcare data industry
BOSTON–(BUSINESS WIRE)–PathAI, a global leader in AI-powered pathology, and GlaxoSmithKline (GSK), today announced a strategic multi-year partnership to accelerate scientific research and drug development programs in oncology and non-alcoholic steatohepatitis (NASH)...
GSK plans expansion of Solara clinical trial strategy platform to optimize design selection across therapeutic areas February 07, 2023 09:00 ET | Source: Cytel WALTHAM, MASS, Feb. 07, 2023 (GLOBE NEWSWIRE) —...
GSK plc (LSE/NYSE: GSK) and Tempus, a US-based precision medicine company, have entered into a three-year collaboration agreement that provides GSK with access to Tempus’ AI-enabled platform, including its library...